Brisk M&A Activity Reviving Indian CRO Scene
This article was originally published in PharmAsia News
Executive Summary
Clinical trial approvals in India have declined sharply in recent months but that has not held back companies active in the sector – both local and global – from making acquisitions. The trend may continue as a few more deals are said to be on the anvil.